Prevention and thorough consideration of drug induced liver injury

Bai WenYuan; Liu Na

Issue 3

Mar. 2011

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2011 > 27(3): 245-247

PDF( 2529 KB)

Prevention and thorough consideration of drug induced liver injury

Bai WenYuan,
Liu Na

Published Date: 2011-03-20

Abstract

Abstract

In recent years,the incidence of drug induced liver injury(DILI) has been increasingly obvious in our country.Acute severe DILI is leading to higher death rate and affecting the public health seriously.The main factors of inducing DILI include abuse of antibiotics,impractical advertisements of medicines,using expired medicine or in inappropriate way in countrysides,etc.For these reasons,we must pay great importance to DILI and take out a feasible way to avoid the occurrence of DILI.
- liver diseases

FullText(HTML)

References(17)

References

[1]Bernal W,Auzinger G,Dhawan A,et al.Acute liver failure[J].Lancet,2010,376(9736):190-201.

[2]Russmann S,Jetter A,Kullak-Ublick GA.Pharma-cogene-tics of drug-induced liver injury[J].Hepatology,2010,52(2):748-761.

[3]尚佳,徐芸,杨玉秀,等.人工肝支持系统治疗药物性肝损伤32例[J].中华肝脏病杂志,2005,13(11):836-838.

[4]王艳,赵龙凤,王勤英.药物性肝损伤66例分析[J].中华肝脏病杂志,2010,18(9):715-716.

[5]Hunt CM.Mitochondrial and immunoallergic injury increase risk of positive drug rechallenge after drug-induced liver injury:A systematic review[J].Hepatology,2010,52(6):2216-2222.

[6]Reuben A,Koch DG,Lee WM.Drug-induced acute liver failure:Results of a U.S.multicenter,prospective study[J].Hepatology,2010,52(6):2065-2076.

[7]Ekins S,Williams AJ,Xu JJ.A predictive ligand-based bayesian model for human drug-induced liver injury[J].Drug Metab Dispos,2010,38(12):2302-2308.

[8]Vuppalanchi R,Hayashi PH,Chalasani N,et al.Dul-oxetine hepatotoxicity:a case-series from the drug-induced liver injury network[J].Aliment Pharmacol Ther,2010,32(9):1174-1183.

[9]Karatopuk DU,G?k?1men A.Effect of tenoxicam on rat liver tissue[J].Turk J Gastroenterol.2010,21(2):146-152.

[10]Kelava T,Cavar I,Culo F.Influence of small doses of various drug vehicles on acetaminophen-induced liver injury[J].Can J Physiol Pharmacol,2010,88(10):960-967.

[11]Schumaker AL,Okulicz JF.Meropenem-induced vanishing bile duct syndrome[J].Pharmacotherapy,2010,30(9):953.

[12]Nú?ez M.Clinical syndromes and consequences of antiretroviral-related hepatotoxicity[J].Hepatology,2010,52(3):1143-1155.

[13]Tai WP,Yue H,Zhai HZ.Zhixue capsule caused seven cases of drug induced hepatitis[J].Hepatogastroenterology,2010,57(99-100):571-572.

[14]Devarbhavi H,Dierkhising R,Kremers WK.Antitu-berculosis therapy drug-induced liver injury and acute liver failure[J].Hepatology,2010,52(2):798-799.

[15]Park WB,Kim W,Lee KL,et al.Antituberculosis drug-induced liver injury in chronic hepatitis and cirrhosis[J].J Infect,2010,61(4):323-329.

[16]Hou FQ,Wang TL,Liu X,et al.The clinical and histological characteristics and outcomes of drug induced chronic liver injury after removing causative drugs[J].Hepatogastroenterology,2010,57(99-100):554-561.

[17]Fontana RJ.Approaches to the study of drug-induced liver injury[J].Clin Pharmacol Ther,2010,88(3):416-419.

Relative Articles

[1]	Xu JiaMin, Tang YingMei. Current status of research on bile duct lesions and related liver diseases[J]. Journal of Clinical Hepatology, 2019, 35(4): 934-936. doi: 10.3969/j.issn.1001-5256.2019.04.051
[2]	Wu JunCheng, Xu MingYi. Research advances in the association between exosomes and liver diseases[J]. Journal of Clinical Hepatology, 2017, 33(9): 1815-1819. doi: 10.3969/j.issn.1001-5256.2017.09.042
[3]	Wang XiaoMing, Wang YueRen. Application of magnetic resonance imaging in hepatobiliary diseases and related challenges[J]. Journal of Clinical Hepatology, 2016, 32(12): 2231-2235. doi: 10.3969/j.issn.1001-5256.2016.12.002
[4]	Hu XianDa, Yue Ying, Wu Peng, Zhou Fei, Luo YuanDai. Research advances in pharmacological effects of Ophiacordyceps sinensis in treatment of liver diseases[J]. Journal of Clinical Hepatology, 2016, 32(4): 793-797. doi: 10.3969/j.issn.1001-5256.2016.04.043
[5]	Huang LanYu, Xu LieMing. Relationship between liver diseases and autophagy[J]. Journal of Clinical Hepatology, 2014, 30(2): 186-188. doi: 10.3969/j.issn.1001-5256.2014.02.022
[6]	Chen Juan, Yin HuaBin. Clinical application of perfusion- weighted MRI in liver diseases[J]. Journal of Clinical Hepatology, 2013, 29(10): 793-796. doi: 10.3969/j.issn.1001-5256.2013.10.018
[7]	Zhang Qian, Han Tao. Research progress in advanced oxidation protein products in liver diseases[J]. Journal of Clinical Hepatology, 2013, 29(8): 581-584. doi: 10.3969/j.issn.1001-5256.2013.08.007
[8]	Wang JianShe. Development of a robust pediatric hepatology program to improve diagnosis and treatment of liver diseases in children[J]. Journal of Clinical Hepatology, 2012, 28(12): 881-883.
[9]	Shen MeiRong, Li ZhongPing, Ding XiaoHong, Chu Feng, Hu DeChang. Clinical significance of liver biopsy in diagnosis and treatment of liver disease[J]. Journal of Clinical Hepatology, 2012, 28(7): 545-547.
[10]	Yang AiTing, Wang BaoEn, You Hong. New evidence of FibroScan′s clinical value for assessing fibrosis, screening liver disease, monitoring chronic liver disease progression, and predicting outcome[J]. Journal of Clinical Hepatology, 2012, 28(9): 644-646.
[11]	He Kun, Wang JinQuan, Tao XiaoGen, Liu Bao, Zhao JingSong, Zhang LinLin, Lu: ShiJin. Incidence and risk fators of hospital-acquired acute liver injury in ICU[J]. Journal of Clinical Hepatology, 2011, 27(1): 96-99+102.
[12]	Wang Bo, Song HuaiYu, Yang JianRong. The progress on the researches of intestinal barrier function changing in patients with liver diseases[J]. Journal of Clinical Hepatology, 2011, 27(8): 893-896.
[13]	Liu Gang. Pediatric liver diseases associated with infection[J]. Journal of Clinical Hepatology, 2011, 27(7): 682-686.
[14]	Xu Fang, Liu Jun, Gao PuJun. Severe liver injury with hyperthyroidism : a case report[J]. Journal of Clinical Hepatology, 2011, 27(10): 1096-1098.
[15]	Liu GuoWang, Cao WuKui. Application of stem cells in liver disease treatment[J]. Journal of Clinical Hepatology, 2011, 27(9): 999-1002.
[16]	Zheng Shan, Shen Zhen. Pediatric liver transplantation:present and future[J]. Journal of Clinical Hepatology, 2011, 27(7): 722-725.
[17]	Tian Hui. Advances on the polycystic liver diseases[J]. Journal of Clinical Hepatology, 2011, 27(4): 446-449.
[18]	Zhang Zhe, Guo JinSheng. The role of high mobility group box 1 in human liver diseases[J]. Journal of Clinical Hepatology, 2011, 27(10): 1116-1120.
[19]	Gao YanHang. Summary of symposium of translational medicine on liver disease[J]. Journal of Clinical Hepatology, 2011, 27(9): 1008-1009.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (3433) PDF downloads(1061)

Prevention and thorough consideration of drug induced liver injury

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Prevention and thorough consideration of drug induced liver injury

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content